SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343) (ATHE) — Nov 19, 2020

ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343)
Date: Nov. 19, 2020 · CIK: 0001131343 · Accession: 0001213900-20-038189

AI Filing Summary & Sentiment

File numbers found in text: 333-250076

Date
November 23, 2020
Author
/s/Kathryn Andrews
Form
CORRESP
Company
ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343)

Letter

VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Re: Alterity Therapeutics Ltd. Registration Statement on Form F-3 File No. 333-250076

Dear Ms. Virginio:

The undersigned, on behalf of Alterity Therapeutics Ltd. (“Alterity”), issuer of the securities covered by the above-referenced Registration Statement, hereby respectfully requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00 p.m. Washington, D.C. time, on Monday, November 23, 2020, or as soon thereafter as possible.

Management of Alterity is aware of its responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the disposition of the securities covered by the above-referenced Registration Statement.

Thank you very much for your courtesy in this matter.

Very truly yours,
/s/Kathryn Andrews

Show Raw Text
CORRESP
1
filename1.htm

Alterity Therapeutics Ltd.

Level 3, 460 Bourke Street, Melbourne, Victoria 3000 Australia

November 18,
2020

VIA EDGAR

Deanna Virginio, Esq.

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    Alterity Therapeutics Ltd.

    Registration Statement on Form F-3

    File No. 333-250076

Dear Ms. Virginio:

The undersigned, on
behalf of Alterity Therapeutics Ltd. (“Alterity”), issuer of the securities covered by the above-referenced Registration
Statement, hereby respectfully requests that the above-referenced Registration Statement be declared effective by the Securities
and Exchange Commission at 4:00 p.m. Washington, D.C. time, on Monday, November 23, 2020, or as soon thereafter as possible.

Management of Alterity
is aware of its responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the
disposition of the securities covered by the above-referenced Registration Statement.

Thank you very much
for your courtesy in this matter.

Very truly yours,

/s/Kathryn Andrews

Kathryn Andrews

Chief Financial Officer